Ahead of the Q2 report we remain positive about the longer-term investment case. Near-term (Q2 and Q3) uncertainty is likely to continue to have an impact on performance. Looking towards the end of the FY and into 21/22 we see strong recovery. We continue to see a fair value in the range of DKK245-285 per share. Q2 results are due on 27 April.

Research feed